Search All News
New combination chemotherapies have improved survival for patients with pancreatic cancer, and oncologist Gulam Manji sees early signs that new treatments in trials may be even better.
Columbia researchers have identified a gene signature in localized prostate cancer that predicts the cancer’s odds of spreading and its response to a common treatment for advanced disease.
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
- August 30, 2017
Prakash Satwani, MD, leads NYP/CUMC's program in CAR-T therapy, a new treatment that uses a patient's own T cells to attack cancer.
- May 4, 2017
Researchers discovered a mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy.
- March 28, 2017
Based on new evidence, laparoscopic surgery should be offered to most women with early-stage endometrial cancer, says Columbia’s gynecologic cancer chief.
- March 27, 2017
A public-private research effort aims to develop more accurate ways of tracking a patient’s response to cancer therapy.
- March 7, 2017
The drug, developed by Columbia and MSK researchers, selectively kills cancer cells and has shown activity against multiple malignancies in pre-clinical studies.